BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19761430)

  • 1. Clinicopathologic and molecular disease prognostication for papillary thyroid cancer.
    Miccoli P; Miccoli M; Antonelli A; Minuto MN
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1261-75. PubMed ID: 19761430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.
    Lam AK; Lo CY
    Ann Surg Oncol; 2006 Feb; 13(2):176-81. PubMed ID: 16411146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
    Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
    Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary carcinoma of the thyroid gland of childhood and adolescence: Morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period.
    Collini P; Mattavelli F; Pellegrinelli A; Barisella M; Ferrari A; Massimino M
    Am J Surg Pathol; 2006 Nov; 30(11):1420-6. PubMed ID: 17063083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
    Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
    Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection.
    Giles Senyurek Y; Tunca F; Boztepe H; Alagöl F; Terzioglu T; Tezelman S
    Surgery; 2009 Dec; 146(6):1188-95. PubMed ID: 19958948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma.
    Uruno T; Miyauchi A; Shimizu K; Nakano K; Takamura Y; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K
    Surg Today; 2004; 34(11):891-5. PubMed ID: 15526121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Extent of surgery affects papillary thyroid cancer.
    Shah JP
    Ann Surg; 2008 Jun; 247(6):1082-3; author reply 1083-4. PubMed ID: 18520248
    [No Abstract]   [Full Text] [Related]  

  • 13. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
    Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
    Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm.
    Perrino M; Vannucchi G; Vicentini L; Cantoni G; Dazzi D; Colombo C; Rodari M; Chiti A; Beck-Peccoz P; Fugazzola L
    Endocr Relat Cancer; 2009 Mar; 16(1):201-10. PubMed ID: 19106146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
    Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine bilateral central lymph node clearance for papillary thyroid cancer.
    Sadowski BM; Snyder SK; Lairmore TC
    Surgery; 2009 Oct; 146(4):696-703; discussion 703-5. PubMed ID: 19789029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary thyroid carcinoma with different histological patterns.
    Lin JD; Hsueh C; Huang BY
    Chang Gung Med J; 2011; 34(1):23-34. PubMed ID: 21392471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lymphadenectomy in the management of papillary carcinoma of the thyroid.
    Rotstein L
    J Surg Oncol; 2009 Mar; 99(4):186-8. PubMed ID: 19170045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
    Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
    Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary management of papillary carcinoma of the thyroid gland.
    Rosenbaum MA; McHenry CR
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.